1 Min Read
Sept 26 (Reuters) - Opsens Inc
* Announces 510 clearance from U.S. Food and drug Administration for Optomonitor II, a multimodality monitor Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.